Higher education in Financial Engineering and Money & Capital Markets. SPK (Turkey CMB) licence. 16 years across institutional markets, research, and quant-driven analytics.
CVS Health earnings surged past tepid forecasts as health benefit costs fell as a share of premiums. CVS stock initially jumped but reversed sharply lower. Management's 2027 outlook shared on the earnings call may have been the trigger.
AI commentary is generated from public news feeds and is not investment advice.